Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Sekcjanaukmedycznych
63
EuropeanIntergroupforChildhoodNon-Hodgkin-Lymphoma,ALCL99InternationalProto-
colfortheTreatmentofChildhoodAnaplasticLargeCellLymphoma.
FaliniB.,PileriS.,ZinzaniP.L.,CarboneA.,ZagonelV.,Wolf-PeetersC.,VerhoefG.,Menestrina
F.,TodeschiniG.,PaulliM.,LazzarinoM.,GiardiniR.,AielloA.,FossH.D.,AraujoI.,Fiz-
zottiM.,PelicciP.G.,FlenghiL.,MartelliM.F.,SantucciA.1999.ALK+lymphoma:clinico-
-pathologicalfindingsandoutcome.Blood,93(8):2697-706.
FerreriA.J.,GoviS.,PileriS.A.,SavageK.J.2012.Anaplasticlargecelllymphoma,ALK-positive.
Crit.Rev.Oncol.Hematol.,83(2):293-302.doi:10.1016lj.critrevonc.2012.02.005.
GallaminiA.,StelitanoC.,CalviR.,BelleiM.,MatteiD.,VitoloU.,MorabitoF.,MartelliM.,Bru-
samolinoE.,IannittoE.,ZajaF.,CortelazzoS.,RigacciL.,DevizziL.,TodeschiniG.,Santini
G.,BrugiatelliM.,FedericoM.,IntergruppoItalianoLinfomi.2004.PeripheralT-celllymp-
homaunspecified(PTCL-U):anewprognosticmodelfromaretrospectivemulticentriccli-
nicalstudy.Blood,103(7):2474-2479.doi:10.1182lblood-2003-09-3080.
GeorgeR.,BhuvanaS.,NairS.,LakshmananJ.1999.Clinicopathologicalprofileofcutaneous
lymphomas--a10yearretrospectivestudyfromsouthIndia.IndianJ.Cancer,36(2-4):109-
119.
GorczycaW
.2014.AtlasofDińerentialDiagnosisinNeoplasticHematopathology.CRCPress,
p.447-461.
IqbalJ.,WeisenburgerD.D.,GreinerT.C.,VoseJ.M.,McKeithanT.,KucukC.,GengH.,Def-
fenbacherK.,SmithL.,DybkaerK.,NakamuraS.,SetoM.,DelabieJ.,BergerF.,LoongF.,
AuW.Y.,KoY.H.,SngI.,ArmitageJ.O.,ChanW.C.2010.Molecularsignaturestoimprove
diagnosisinperipheralT-celllymphomaandprognosticationinangioimmunoblasticT-cell
lymphoma.Blood,115(5):1026-1036.doi:10.1182lblood-2009-06-227579.
IrshaidL.,XuM.L.2020.ALCLbyanyothername:themanyfacetsofanaplasticlargecelllymp-
homa.Pathology,52(1):100-110.doi:10.1016lj.pathol.2019.09.007.
JańeE.,ArberD.,CampoE.,Quintanilla-MartinezL.,AttilioOraziA.2016.Hematopathology.
2ndEd.,Elsevier,p.673-691.
LeeJ.S.,ChoiS.J.,KimL.,ParkI.S.,HanJ.Y.,KimJ.M.,ChuY.C.2019.ALK-positiveanaplastic
largecelllymphomawithamonomorphicsmall-cellpatternmasqueradingasinflammato-
rygastriclesions.MalaysJ.Pathol.,41(2):213-222.
LuY.,ZhaoX.,WangE.,ChenW.,HuangQ.2010.ALK-negativeanaplasticlargecelllympho-
mawithextensiveperipheralbloodandbonemarrowinvolvementsmanifestedas“leukemic
phase”
.Leuk.Res.,34(4):475-482.doi:10.1016lj.leukres.2009.07.034.
LynchR.C.,GratzingerD.,AdvaniR.H.2017.ClinicalImpactofthe2016UpdatetotheWHO
LymphomaClassification.Curr.TreatOptionsOncol.,18(7):45.doi:10.1007ls11864-017-
0483-z.
Montes-MojarroI.A.,SteinhilberJ.,BonzheimI.,Quintanilla-MartinezL.,FendF.2018.Te
PathologicalSpectrumofSystemicAnaplasticLargeCellLymphoma(ALCL).Cancers(Ba-
sel),10(4):107.doi:10.3390lcancers10040107.
MoodleyN.,NombonaP.,MosamA.2019.PrimaryCutaneousAnaplasticLarge-CellLympho-
ma.Dermatopathology(Basel),6(2):163-169.doi:10.1159l000500259.
MuzzafarT.,WeiE.X.,LinP.,MedeirosL.J.,JorgensenJ.L.2009.Flowcytometricimmunop-
henotypingofanaplasticlargecelllymphoma.Arch.Pathol.Lab.Med.,133(1):49-56.doi:
10.5858l133.1.49.
PapalasJ.A.,WangE.2016.Clinicalandhistopathologicoverlapbetweensubcutaneouspan-
niculitis-likeT-celllymphomawithsystemicfeaturesandsmallcellCD8+ALK+systemic
anaplasticlargecelllymphomawithcutaneousinvolvement.J.Cutan.Pathol.,43(5):480-
481.doi:10.1111lcup.12710.
